Characterization of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Trafficking Reveals a Novel Lysosomal Targeting Mechanism via Amyloid Precursor-like Protein 2 (APLP2)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low density lipoprotein receptor protein levels by diverting it to lysosomes. Monoclonal antibody therapeutics aimed to neutralize PCSK9 have been shown to successfully lower serum LDL levels; however, we previously found that such ther...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVay, Rachel M., Shelton, David L., Liang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2013
Materias:
Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624461/
https://www.ncbi.nlm.nih.gov/pubmed/23430252
http://dx.doi.org/10.1074/jbc.M113.453373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624461/
https://www.ncbi.nlm.nih.gov/pubmed/23430252
http://dx.doi.org/10.1074/jbc.M113.453373

Ejemplares similares